Combined Modality TherapyRadiotherapy, AdjuvantAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeChemotherapy, AdjuvantCyclophosphamideRadiation DosageRadiation, IonizingCisplatinDoxorubicinRadiation InjuriesDisease-Free SurvivalAntineoplastic AgentsDose-Response Relationship, RadiationSurvival AnalysisLymphatic IrradiationVincristineRadiotherapyEtoposideAntibodies, Monoclonal, HumanizedRadiation ToleranceNeoplasm StagingRadiationBreast NeoplasmsNeoadjuvant TherapyOrganoplatinum CompoundsBleomycinSurvival RateMethotrexateLung NeoplasmsRadiation ProtectionFluorouracilCarboplatinPrognosisRadiation MonitoringNeoplasm Recurrence, LocalVinblastineHodgkin DiseaseTransplantation, AutologousMechlorethamineCarcinoma, Non-Small-Cell LungHematopoietic Stem Cell MobilizationSalvage TherapyGranulocyte Colony-Stimulating FactorProcarbazinePrednisoneNeoplasm MetastasisAntibodies, Monoclonal, Murine-DerivedHematopoietic Stem Cell TransplantationKaplan-Meier EstimateAntibodies, MonoclonalColorectal NeoplasmsFollow-Up StudiesRadiation OncologyClinical Trials as TopicCarcinoma, Squamous CellEpirubicinRadiotherapy DosageDrug Administration ScheduleRemission InductionLymphoma, Large B-Cell, DiffuseRadiation PneumonitisProspective StudiesRadiation Injuries, ExperimentalCosmic RadiationPaclitaxelNeoplasmsLeucovorinNeoplasms, Radiation-InducedGamma RaysTime FactorsInduction ChemotherapyTaxoidsBackground RadiationDeoxycytidineDrug Resistance, NeoplasmIfosfamideAntimetabolites, AntineoplasticRadiometryRetrospective StudiesCarcinoma, Small CellBrain NeoplasmsAntineoplastic Agents, AlkylatingAdenocarcinomaRadiation-Sensitizing AgentsUltraviolet RaysRadiation EffectsAnthracyclinesRadiation-Protective AgentsCytarabineDose FractionationLymphoma, Non-HodgkinDacarbazineChemotherapy, Cancer, Regional PerfusionRadiotherapy, ConformalOvarian NeoplasmsVomitingAntineoplastic Agents, PhytogenicCell Line, TumorTesticular Neoplasms